High Point Advisor Group LLC Pfizer Inc Transaction History

High Point Advisor Group LLC

$1.4 Billion
Q1 2024

A detailed history of High Point Advisor Group LLC transactions in Pfizer Inc stock. As of the latest transaction made, High Point Advisor Group LLC holds 195,988 shares of PFE stock, worth $5.45 Million. This represents 0.39% of its overall portfolio holdings.

Number of Shares

195,988

Previous 187,201 4.69%

Holding current value

$5.45 Million

Previous $5.39 Million 0.91%

% of portfolio

0.39%

Previous 0.42%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$25.89 - $29.73 $227,495 - $261,237	8,787 Added 4.69%	195,988 $5.44 Million
Q4 2023 Mar 26, 2024	BUY	$26.13 - $33.94 $1.66 Million - $2.15 Million	63,392 Added 51.2%	187,201 $5.39 Million
Q2 2022 Aug 15, 2022	SELL	$46.53 - $55.17 $667,007 - $790,861	-14,335 Reduced 10.38%	123,809 $6.53 Million
Q3 2021 Nov 15, 2021	BUY	$39.25 - $50.42 $677,808 - $870,702	17,269 Added 14.29%	138,144 $5.94 Million
Q2 2021 Jul 29, 2021	BUY	$35.91 - $40.68 $924,790 - $1.05 Million	25,753 Added 27.07%	120,875 $4.73 Million

Q1 2021 Apr 12, 2021	BUY	$33.49 - $37.77 $202,714 - $228,621	6,053 Added 6.8%	95,122 $3.48 Million
Q4 2020 Feb 10, 2021	BUY	$33.47 - $42.56 $650,656 - $827,366	19,440 Added 27.92%	89,069 $3.12 Million
Q3 2020 Nov 06, 2020	BUY	$31.75 - $37.25 $61,055 - $71,631	1,923 Added 2.84%	69,629 $2.53 Million
Q2 2020 Aug 13, 2020	SELL	$30.12 - $36.54 $138,913 - $168,522	-4,612 Reduced 6.38%	67,706 $2.28 Million
Q1 2020 May 01, 2020	BUY	$27.03 - $38.62 $1.88 Million - $2.69 Million	69,615 Added 2575.47%	72,318 $2.7 Million
Q1 2020 Apr 27, 2020	SELL	$27.03 - $38.62 $2 Million - $2.86 Million	-74,059 Reduced 96.48%	2,703 $72.3 Million
Q4 2019 Feb 13, 2020	BUY	$32.92 - $37.36 $405,870 - $460,611	12,329 Added 19.13%	76,762 $3.1 Million
Q3 2019 Nov 12, 2019	BUY	$32.49 - $42.13 $73,622 - $95,466	2,266 Added 3.65%	64,433 $2.39 Million
Q2 2019 Aug 15, 2019	SELL	$36.98 - $41.52 $137,269 - $154,122	-3,712 Reduced 5.63%	62,167 $2.66 Million
Q1 2019 May 08, 2019	SELL	$37.5 - $41.2 $146,400 - $160,844	-3,904 Reduced 5.59%	65,879 $2.69 Million
Q4 2018 Feb 20, 2019	SELL	$38.47 - $43.86 $9,502 - $10,833	-247 Reduced 0.35%	69,783 $2.97 Million
Q3 2018 Oct 24, 2018	SELL	$34.47 - $41.81 $36,021 - $43,691	-1,045 Reduced 1.47%	70,030 $3.11 Million
Q2 2018 Aug 20, 2018	BUY	$32.98 - $35.16 $292,664 - $312,009	8,874 Added 14.27%	71,075 $2.94 Million
Q1 2018 Jun 11, 2018	BUY	$31.91 - $37.02 $34,047 - $39,500	1,067 Added 1.75%	62,201 $2.28 Million
Q4 2017 Feb 15, 2018	BUY	$33.26 - $35.29 $17,128 - $18,174	515 Added 0.85%	61,134 $2.14 Million
Q3 2017 Nov 06, 2017	BUY	$31.0 - $34.15 $1.88 Million - $2.07 Million	60,619	60,619 $2.15 Million

Others Institutions Holding PFE

# of Institutions

3,158

Shares Held

3.68B

Call Options Held

67.4M

Put Options Held

113M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $156B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of High Point Advisor Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Point Advisor Group LLC with notifications on news.

Account

High Point Advisor Group LLC Pfizer Inc Transaction History